FDA Mandates Major Labeling Overhaul for All Opioid Pain Medications
On July 31, 2025, the U.S. Food and Drug Administration (FDA) announced sweeping safety labeling changes for all opioid pain medications. This mandate is aimed at making the risks of long-term opioid use — including misuse, addiction, and overdose — clearer for both healthcare professionals and patients (fda.gov). Why This Matters The decision stems from […]
Sandoz Recalls Cefazolin Injection After Mispackaging Error: What Healthcare Providers Need to Know
A Nationwide Recall Sparks Concern On June 27, 2025, Sandoz Inc., in collaboration with the U.S. Food and Drug Administration (FDA), announced a voluntary nationwide recall of one lot of Cefazolin for Injection USP, 1 g per vial due to a serious mispackaging issue. A complaint revealed that four vials labeled as Penicillin G Potassium (20 […]
Understanding Signal Management in Pharmacovigilance: A Key Pillar of Drug Safety
In today’s dynamic regulatory environment, continuous monitoring of a medicine’s safety profile is more critical than ever. One of the most essential activities that ensures patient safety post-authorisation is signal management. If you’re working in regulatory affairs, drug safety, or pharmacovigilance, this blog will guide you through the European Medicines Agency’s (EMA) approach to signal […]